Hunan Jiudian Pharmaceutical Co., Ltd. (SHE:300705)

China flag China · Delayed Price · Currency is CNY
15.01
+0.10 (0.67%)
Mar 10, 2026, 3:04 PM CST
-11.39%
Market Cap 7.37B
Revenue (ttm) 3.05B
Net Income (ttm) 469.00M
Shares Out 494.11M
EPS (ttm) 0.92
PE Ratio 16.27
Forward PE 12.17
Dividend 0.31 (2.10%)
Ex-Dividend Date May 26, 2025
Volume 5,300,547
Average Volume 4,749,898
Open 14.68
Previous Close 14.91
Day's Range 14.68 - 15.09
52-Week Range 14.41 - 20.66
Beta 0.02
RSI 44.33
Earnings Date Apr 25, 2026

About SHE:300705

Hunan Jiudian Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China and internationally. Its products portfolio includes Pantoprazole Sodium Enteric-coated, Ferrous Succinate, Rosuvastatin Calcium, Ebastine, and Rabeprazole Sodium Enteric-coated Tablets; and Acetylcysteine Granules, Potassium Sodium Hydrogen Citrate Granules, Loxoprofen Sodium Gel Patch, and Ketoprofen gel patch. The company also offers drugs for analgesic, cardio-cerebrovascular, anti-infection, digestive and urinary system, and br... [Read more]

Sector Healthcare
Founded 2001
Employees 2,221
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300705
Full Company Profile

Financial Performance

In 2024, SHE:300705's revenue was 2.93 billion, an increase of 8.85% compared to the previous year's 2.69 billion. Earnings were 512.38 million, an increase of 39.13%.

Financial Statements

News

There is no news available yet.